Visiongain

Clinical-stage stem cell companies are targeting ischaemic diseases of the cardiovascular and cerebrovascular systems, the two biggest causes of death worldwide in 2012. More than 20 stem cell products tackling those diseases are in clinical trials.

LONDON, UK. 15th August 2013: Investment in shale oil will increase over the next decade as countries around the world seek to emulate the rapid development the industry has taken in the United States.

Strong growth for Revlimid and Velcade in multiple myeloma will stimulate that expansion, as will the launch of new therapies for chronic myeloid leukaemia (CML) in the US and EU in 2012 and 2013.

LONDON, UK. 14th August 2013: Visiongain’s analysis indicates that the global automotive tire market will see sales of 1.08 Billion tires in 2013, as the global automotive tire market moves to a new growth phase.

The study forecasts that the overall market for pain relieving drugs will grow steadily from 2013 to 2023. The world pain-treating drug market is a high-revenue industry with a high public and healthcare profile.

LONDON, UK. 02nd August 2013: Visiongain’s new report The Coal Power Decommissioning Market 2013-2023 indicates that the global market for coal power decommissioning will be worth $1.08bn in 2013.

In 2012, biomarker discovery dominated that field. That sector is expected to face strong competition from another fast-growing submarket – biomarker diagnostics. This is owing to biomarkers increasingly being used in companion diagnostic tests.

London, UK. 01st August 2013: Wearable technology has been utilised by the military for several years now, with soldiers wearing sensors in their uniforms and helmet mounted cameras.

Visiongain predicts the IBD treatment market will grow in revenues because of the increased use of biological therapies (biologics), such as monoclonal antibodies (mAbs). They dominate the market for revenue generation.

London, 22nd July 2013: Although recent economic turmoil has affected many industries worldwide, the MAP & CAP industry continue to stay robust and in many countries is expected to show a strong performance.